 |
|
|
Forms 8-K (archive)
Below please find topical corporate news covering the financial situation of the company, the development and marketing progress of our projects and products as well as changes in management. The entire news text is available as PDF-File.
 |
04.12.2007
|
Company News
|
|
|
|
Sangui partnership enters a new phase:
Second wound ambulance established in Monterrey
State health authorities support approval and practical use of wound management products
Definite planning starts for blood additive project
|
|
|
22.10.2007
|
Company News
|
|
|
|
Medicoforum and Sangui part
EU HEMO2SPRAY authorization to be carried out by successful CHITOSKIN team
|
|
|
21.09.2007
|
Company News
|
|
|
|
Sangui Announces Change of Auditor
|
|
|
06.08.2007
|
Company News
|
|
|
|
Products and Marketing Registration for the Arabian Markets on Schedule
Hemospray authorization to be underpinned by additional case studies
|
|
|
23.05.2007
|
Company News
|
|
|
|
Arabian companies will start selling Sangui products in the course of next few months
|
|
|
17.04.2007
|
Company News
|
|
|
|
Sangui succeeds in replacing porcine raw material in Chitoskin wound pads
|
|
|
12.04.2007
|
Company News
|
|
|
|
TYCOON Venture Capital & Investment Ltd. intends to finance Sangui blood additive and products
Participation in SanguiBioTech GmbH and loan volume of up to EUR 7.5 million
|
|
|
07.02.2007
|
Company News
|
|
|
|
Tycoon Consulting (UK) intends to market Sangui products in several Arab countries
|
|
|
17.10.2006
|
Company News
|
|
|
|
Breakthrough for Sangui Oxygen Carriers
Sangui enters new era of its history and starts blood additive authorization process. Mexican partner takes the lead in promoting live-saving medical innovation
ERC Nano Med and SanguiBioTech sign comprehensive cooperation contract, Medicoforum in charge of project management
|
|
|
16.10.2006
|
Company News
|
|
|
|
Sangui Wound Management Products Head for the Mexican Market
ERC Nano Med obtains exclusive distribution rights and starts authorization process
|
|
|
13.09.2006
|
Company News
|
|
|
|
Sangui and Medicoforum group cooperate in HEMO2SPRAY wound spray certification and distribution
|
|
|
29.08.2006
|
Company News
|
|
|
|
PURE MO2ISTURE anti-aging cosmetics now for sale in Sangui's new internet shop
|
|
|
06.07.2006
|
Company News
|
|
|
|
German Forces test CHITOSKIN wound pads
|
|
|
03.07.2006
|
Company News
|
|
|
|
Medicoforum starts entering certification process of Sangui's HEMO2SPRAY wound spray
|
|
|
30.06.2006
|
Company News
|
|
|
|
CHITOSKIN paper meets strong interest at European Wound Management Association Conference
|
|
|
11.04.2006
|
Company News
|
|
|
|
Sangui reports encouraging product sales
in Q2 and Q3
|
|
|
16.03.2006
|
Company News
|
|
|
|
Authorization of Sangui's HEMO2SPRAY to start in Turkey
|
|
|
15.03.2006
|
Company News
|
|
|
|
Sangui Body Gel Sales Start in Argentina
Distributor Plans to Tackle Other South American Markets
|
|
|
06.02.2006
|
Company News
|
|
|
|
Key hemoglobin related US and PCT patents granted to Sangui
|
|
|
26.01.2006
|
Company News
|
|
|
|
CHITOSKIN export gains momentum
Biggest wound pad order so far destined for distribution in another EU member country
|
|
|
23.01.2006
|
Company News
|
|
|
|
Kaufmann sells
Stocks of Sangui cosmetics completely sold, marketing partner asks for new supplies
|
|
|
23.11.2005
|
Company News
|
|
|
|
Medicoforum to promote CE certification of Sangui's HEMO2SPRAY
|
|
|
17.11.2005
|
Company News
|
|
|
|
Sangui innovative wound pad technology meets increasing attention
|
|
|
26.10.2005
|
Company News
|
|
|
|
Sangui reports flat sales in Q1, while significant orders were coming in
|
|
|
24.10.2005
|
Company News
|
|
|
|
CHITOSKIN met overwhelming response at European Wound Healing Congress
|
|
|
25.05.2005
|
Company News
|
|
|
|
Centurion initiates authorization and subsequent marketing of Sangui's Body Gel in Korea, China,Taiwan and Japan
|
|
|
19.04.2005
|
Company News
|
|
|
|
Beese starts marketing activities for Sangui's CHITOSKIN wound pads
Sangui starts to develop additional hemostatic wound pad
|
|
|
17.03.2005
|
Company News
|
|
|
|
Joop - Wunderkind
|
|
|
16.03.2005
|
Company News
|
|
|
|
Sangui sells first quantity of anti-cellulite gel
|
|
|
14.03.2005
|
Company News
|
|
|
|
Sangui and BiologiQ negotiate wound pad sales in the Benelux countries
|
|
|
10.03.2005
|
Company News
|
|
|
|
Sangui obtains first product authorization
CHITOSKIN wound pad gets CE mark authorizing sales in European Union
|
|
|
08.03.2005
|
Company News
|
|
|
|
Sangui and Green Cross plan to evaluate options for a possible cooperation
|
|
|
28.02.2005
|
Company News
|
|
|
|
Sangui's annual report filed,
quarterly reports under preparation
|
|
|
17.02.2005
|
Company News
|
|
|
|
Thomas Striepe elected new Director
Cash contribution of $375,000 through issuance of new shares
|
|
|
29.11.2004
|
Company News
|
|
|
|
New Sangui product helps to reduce cellulite - Patent application filed
|
|
|
18.11.2004
|
Company News
|
|
|
|
Biosteel Medical GbR, Aachen, and SanguiBioTech GmbH agree on research cooperation
|
|
|
16.11.2004
|
Company News
|
|
|
|
SanguiBioTech GmbH and Karl Beese GmbH & Co. plan to jointly distribute CHITOSKIN® wound pads
|
|
|
24.09.2004
|
Company News
|
|
|
|
Sangui to continue wound spray authorization alone or with new partners
Cooperation contract re Hemospray not to be signed
|
|
|
03.09.2004
|
Company News
|
|
|
|
Contract with pharmaceuticals company still pending
|
|
|
12.07.2004
|
Company News
|
|
|
|
Mercatura starts marketing Sangui skin care product in September, 2004
|
|
|
21.06.2004
|
Company News
|
|
|
|
SanguiBioTech and German Pharmaceutical Company
Plan Joint Development of Haemoglobin Wound Spray
|
|
|
06.05.2004
|
Company News
|
|
|
|
Sangui and Mercatura sign letter of intend
to market anti-aging formulation
|
|
|
17.02.2004
|
Company News
|
|
|
|
Several company news
|
|
|
21.11.2003
|
Company News
|
|
|
|
Several news
|
|
|
24.09.2003
|
Company News
|
|
|
|
Malek resigns from Sangui Boards
|
|
|
01.09.2003
|
Company News
|
|
|
|
Conversion of German Sangui subsidiary to a GmbH
|
|
|
16.07.2003
|
Company News
|
|
|
|
New directors join Sangui Board
|
|
|
12.06.2003
|
Company News
|
|
|
|
Sangui cost reduction continued
|
|
|
20.02.2003
|
Company News
|
|
|
|
Sangui focusses completely on market entry of its haemoglobin bearing nano preparations
|
|
|
09.12.2002
|
Company News
|
|
|
|
Sangui refrains from taking litigation lawsuit to conclusion
|
|
|
01.11.2002
|
Sangui News - November 2002
|
|
|
|
Sangui reports on progress of cost reduction program in Q1 of fiscal 2003
|
|
|
31.10.2002
|
Company News
|
|
|
|
Sangui Bio Tech Director resigns
|
|
|
30.09.2002
|
Company News
|
|
|
|
Sangui starts refocussing programme aimed at cost reduction and fast market entry
|
|
|
01.07.2002
|
Sangui News - July 2002
|
|
|
|
Several company news
|
|
|
14.05.2002
|
Sangui News - EXTRA May 2002
|
|
|
|
Several company news
|
|
|
Remark:
|
Some of the statements contained in this news release discuss future expectations, contain projections of results of operation or financial condition or state other "forward-looking" information. These statements are subject to known and unknown risks, uncertainties, and other factors that could cause the actual results to differ materially from those contemplated by the statements. The forward-looking information is based on various factors and is derived using numerous assumptions. Important factors that may cause actual results to differ from projections include, among many others, the ability of the Company to raise sufficient capital to meet operating requirements.
Words such as "anticipates", "expects", "intends", "plans", "believes", "seeks", "estimates" and variations of such words and similar expressions are intended to identify such forward-looking statements. Unless required by law, the Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
|
|
|
|
|
